Frequently Asked Questions
The market is segmented based on , By Type (Immune Enhancer & Antivirals, Sleep Enhancing, CNS Stimulants, Others), End-User (Hospitals, Clinics, Research Institutes) - Industry Trends and Forecast to 2030.
.
The Global Chronic Fatigue Syndrome Market size was valued at USD 47.20 USD Million in 2022.
The Global Chronic Fatigue Syndrome Market is projected to grow at a CAGR of 4.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Cortene , Hemispherx Biopharma , Otsuka Pharmaceutical Co, Mitsubishi Tanabe Pharma Corporation, Tonix Pharmaceuticals Holding Corp, Solve ME/CFS Initiative, Johnson & Johnson, Novartis AG, Pfizer , GlaxoSmithKline plc, Merck & Co, Sanofi, AstraZeneca plc, Eli Lilly and Company, Bristol Myers Squibb Company, Biogen , Takeda Pharmaceutical Company Limited, Amgen , Gilead Sciences, .
The market report covers data from the U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)..
